Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Dicker

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
American Journal of Clinical Oncology|February 28, 2015
Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen TherapiesTu D Dan, Harriet B Eldredge-Hindy, Jean Hoffman-Censits, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade gliomaEvan J Wuthrick, Walter J Curran, Kevin Camphausen, et al.
Radiation Oncology (London, England)|December 29, 2012
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort studyXinglei Shen, David W Andrews, Robert C Sergott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
Novel actions of next-generation taxanes benefit advanced stages of prostate cancerRenée de Leeuw, Lisa D Berman-Booty, Matthew J Schiewer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and RadioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2020
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate CancerJianqing Lin, Robert B Den, Jacob Greenspan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2014
The retinoblastoma tumor suppressor modulates DNA repair and radioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Reanalysis of cancer drugs: old drugs, new tricksGeorge F Vande Woude, Gary J Kelloff, Raymond W Ruddon, et al.
American Journal of Clinical Oncology|September 21, 2013
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomesMark V Mishra, Eli D Scher, Jocelyn Andrel, et al.
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
American Journal of Clinical Oncology|February 28, 2015
Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen TherapiesTu D Dan, Harriet B Eldredge-Hindy, Jean Hoffman-Censits, et al.
International Journal of Radiation Oncology, Biology, Physics|August 9, 2014
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade gliomaEvan J Wuthrick, Walter J Curran, Kevin Camphausen, et al.
Radiation Oncology (London, England)|December 29, 2012
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort studyXinglei Shen, David W Andrews, Robert C Sergott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
Novel actions of next-generation taxanes benefit advanced stages of prostate cancerRenée de Leeuw, Lisa D Berman-Booty, Matthew J Schiewer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Correction: The Retinoblastoma Tumor Suppressor Modulates DNA Repair and RadioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2020
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate CancerJianqing Lin, Robert B Den, Jacob Greenspan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2014
The retinoblastoma tumor suppressor modulates DNA repair and radioresponsivenessChellappagounder Thangavel, Ettickan Boopathi, Steve Ciment, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Reanalysis of cancer drugs: old drugs, new tricksGeorge F Vande Woude, Gary J Kelloff, Raymond W Ruddon, et al.
American Journal of Clinical Oncology|September 21, 2013
Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomesMark V Mishra, Eli D Scher, Jocelyn Andrel, et al.
Pageof 29